in

Radium-223 Plus Enzalutamide Ups Survival in Prostate Cancer

Source link : https://www.newshealth.biz/health-news/radium-223-plus-enzalutamide-ups-survival-in-prostate-cancer/

BARCELONA, Spain — Adding bone-targeting radium-223 (Ra223) to the androgen receptor pathway inhibitor enzalutamide (Xtandi) in patients with metastatic castration-resistant prostate cancer and bone metastases significantly improves survival outcomes, according to the first results from the PEACE III trial. The research, presented at the European Society for Medical Oncology (ESMO) Annual Meeting 2024, demonstrated a […]

Author : News Health

Publish date : 2024-09-17 06:26:33

Copyright for syndicated content belongs to the linked Source.

PM’s Birthday and 100 Days in Office: Live Updates on Job Creation – Economy News Today September 17, 2024

Pere, le Guardiola de Gérone : avec Pep, leurs parcours « se sont rejoints à travers le football »